Oxidative Stress and Arterial Dysfunction in Peripheral Artery Disease.
Ahmed IsmaeelRobert S BrumbergJeffrey S KirkEvlampia PapoutsiPatrick J FarmerWilliam T BohannonRobert S SmithJack L EidsonIan SawickiPanagiotis KoutakisPublished in: Antioxidants (Basel, Switzerland) (2018)
Peripheral artery disease (PAD) is an atherosclerotic disease characterized by a narrowing of the arteries in the lower extremities. Disease manifestations are the result of more than just reduced blood flow, and include endothelial dysfunction, arterial stiffness, and inflammation. Growing evidence suggests that these factors lead to functional impairment and decline in PAD patients. Oxidative stress also plays an important role in the disease, and a growing amount of data suggest a link between arterial dysfunction and oxidative stress. In this review, we present the current evidence for the involvement of endothelial dysfunction, arterial stiffness, and inflammation in the pathophysiology of PAD. We also discuss the links between these factors and oxidative stress, with a focus on nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2)-derived reactive oxygen species (ROS) and decreased nitric oxide (NO) bioavailability. Finally, the potential therapeutic role of NOX2 antioxidants for improving arterial function and functional status in PAD patients is explored.
Keyphrases
- oxidative stress
- reactive oxygen species
- peripheral artery disease
- dna damage
- end stage renal disease
- blood flow
- nitric oxide
- diabetic rats
- ischemia reperfusion injury
- newly diagnosed
- ejection fraction
- induced apoptosis
- blood pressure
- chronic kidney disease
- peritoneal dialysis
- cell death
- big data
- heat shock
- soft tissue
- nitric oxide synthase